Hannah Deresiewicz

Investor Relations Contact at FORTY SEVEN, INC.

Health Technology

Finance

Profile

Hannah Deresiewicz is currently working as the Head of Investor Relations at KALA BIO, Inc. and as an Investor Relations Contact at Forty Seven, Inc. She previously worked as a Senior Associate at Stern Investor Relations, Inc. starting in 2013.

Hannah Deresiewicz active positions

Companies	Position	Start
FORTY SEVEN, INC.	Investor Relations Contact	-
KALA BIO, INC.	Investor Relations Contact	-
Stern Investor Relations, Inc. Stern Investor Relations, Inc. Investment ManagersFinance Stern Investor Relations, Inc. provides investor relations services to healthcare and biotechnology companies. The company was founded in 2009 and is headquartered in New York, NY.	Corporate Officer/Principal	2013-05-31

All active positions of Hannah Deresiewicz

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Hannah Deresiewicz's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
KALA BIO, INC.	Health Technology

Private companies	2
Forty Seven, Inc. Forty Seven, Inc. Pharmaceuticals: MajorHealth Technology Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities. The company was founded by Irving L. Weissman, Ravi Majeti, Mark Chao and Jens-Peter Volkmer in 2014 and is headquartered in Menlo Park, CA.	Health Technology
Stern Investor Relations, Inc. Stern Investor Relations, Inc. Investment ManagersFinance Stern Investor Relations, Inc. provides investor relations services to healthcare and biotechnology companies. The company was founded in 2009 and is headquartered in New York, NY.	Finance